The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zofran 16 mg Suppositories

16 milligram(s) Suppository

Novartis Ireland LimitedPA0896/036/004

Main Information

Trade NameZofran 16 mg Suppositories
Active SubstancesOndansetron
Strength16 milligram(s)
Dosage FormSuppository
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/036/004

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA01 ondansetron

Status

Authorised/WithdrawnAuthorised
Licence Issued01/05/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back